News Scandinavian ChemoTech AB

Equities

CMOTEC B

SE0009242654

Delayed Nasdaq Stockholm Other stock markets 11:59:51 30/04/2024 BST			5-day change	1st Jan Change
2.23 ^SEK	-.--%		+1.36%	-17.41%

04-22	Scandinavian Chemotech AB Obtains Approval of the Third and Last Patent Application in India	CI
04-10	Scandinavian ChemoTech AB Attains Progress by Obtaining Patent Protection for Two Essential Patents in India	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ChemoTech obtain approval of the third and last patent application in India	04-22	AQ
Scandinavian Chemotech AB Obtains Approval of the Third and Last Patent Application in India	04-22	CI
ChemoTech attains progress by obtaining patent protection for two essential patents in India	04-10	AQ
Scandinavian ChemoTech AB Attains Progress by Obtaining Patent Protection for Two Essential Patents in India	04-10	CI
Scandinavian ChemoTech's Animal Care embarks on an exciting journey along with Equitom to forge a cutting-edge Centre of Excellence	04-05	AQ
ChemoTech secures order from the largest European state-of-the-art equine (horse) clinic	03-27	AQ
Scandinavian ChemoTech Secures Order from the Largest European Equine Clinic	03-27	CI
IQwave™ Receives Certification for Tumour Treatment in Singapore	03-25	AQ
Scandinavian ChemoTech AB's IQwave Receives Certification for Tumour Treatment in Singapore	03-25	CI
Scandinavian ChemoTech - Weathering the storm	03-22	AQ
ChemoTech signs new agreement with a private hospital & medical college	03-20	AQ
Scandinavian ChemoTech AB Signs New Agreement with Chhatrapati Shivaji Subharti Hospital & Medical College	03-20	CI
ChemoTech adapts its strategy and short-term targets for Human Care	03-20	AQ
Scandinavian ChemoTech AB (publ) Year-End Report January - December 2023 - Executive Summary	03-05	AQ
Scandinavian ChemoTech AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	03-05	CI
Scandinavian ChemoTech AB Reports Earnings Results for the Full Year Ended December 31, 2023	03-05	CI
New order received for the Innovative TSE Cancer Treatment Technology	02-12	AQ
Scandinavian ChemoTech AB Receives Order for USD 30,000 from One of Its Largest Clients in the United States	02-12	CI
Transcript : Scandinavian ChemoTech AB - Special Call	01-29
Invitation to Presentation on the recent Ethics Committee Approval and Clinical Strategy	01-26	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Scandinavian ChemoTech AB

Equities

CMOTEC B

SE0009242654

Summary

Filters